Dai-ichi Life Insurance Company’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.27M | Buy |
16,832
+246
| +1% | +$134K | 0.24% | 93 |
|
|
2025
Q4 | $9.61M | Sell |
16,586
-1,546
| -9% | -$874K | 0.25% | 84 |
|
|
2025
Q3 | $8.79M | Buy |
18,132
+2,438
| +16% | +$1.13M | 0.22% | 99 |
|
|
2025
Q2 | $6.36M | Sell |
15,694
-2,215
| -12% | -$926K | 0.18% | 122 |
|
|
2025
Q1 | $8.91M | Buy |
17,909
+7,152
| +66% | +$3.87M | 0.26% | 93 |
|
|
2024
Q4 | $5.6M | Sell |
10,757
-6,950
| -39% | -$3.82M | 0.15% | 148 |
|
|
2024
Q3 | $11M | Buy |
17,707
+168
| +1% | +$99.4K | 0.28% | 88 |
|
|
2024
Q2 | $9.7M | Sell |
17,539
-1,285
| -7% | -$736K | 0.24% | 104 |
|
|
2024
Q1 | $10.9M | Sell |
18,824
-349
| -2% | -$196K | 0.25% | 94 |
|
|
2023
Q4 | $10.2M | Sell |
19,173
-13,374
| -41% | -$6.47M | 0.21% | 102 |
|
|
2023
Q3 | $16.5M | Buy |
32,547
+8,497
| +35% | +$4.53M | 0.36% | 59 |
|
|
2023
Q2 | $12.5M | Sell |
24,050
-6,552
| -21% | -$3.54M | 0.26% | 78 |
|
|
2023
Q1 | $17.6M | Buy |
30,602
+429
| +1% | +$242K | 0.39% | 59 |
|
|
2022
Q4 | $16.6M | Sell |
30,173
-13,544
| -31% | -$7.18M | 0.38% | 53 |
|
|
2022
Q3 | $22.2M | Buy |
43,717
+5,208
| +14% | +$2.91M | 0.55% | 36 |
|
|
2022
Q2 | $20.9M | Sell |
38,509
-6,413
| -14% | -$3.53M | 0.47% | 46 |
|
|
2022
Q1 | $26.5M | Sell |
44,922
-3,190
| -7% | -$1.83M | 0.42% | 57 |
|
|
2021
Q4 | $32.1M | Sell |
48,112
-2,167
| -4% | -$1.35M | 0.41% | 46 |
|
|
2021
Q3 | $28.7M | Sell |
50,279
-971
| -2% | -$533K | 0.37% | 48 |
|
|
2021
Q2 | $25.9M | Buy |
51,250
+2,781
| +6% | +$1.31M | 0.32% | 58 |
|
|
2021
Q1 | $22.1M | Sell |
48,469
-688
| -1% | -$328K | 0.3% | 57 |
|
|
2020
Q4 | $22.9M | Buy |
49,157
+7,850
| +19% | +$3.68M | 0.33% | 51 |
|
|
2020
Q3 | $18.2M | Buy |
41,307
+5,126
| +14% | +$2.12M | 0.33% | 55 |
|
|
2020
Q2 | $13.1M | Sell |
36,181
-4,420
| -11% | -$1.48M | 0.3% | 61 |
|
|
2020
Q1 | $11.5M | Sell |
40,601
-1,396
| -3% | -$440K | 0.44% | 55 |
|
|
2019
Q4 | $13.6M | Buy |
41,997
+5,319
| +15% | +$1.61M | 0.31% | 74 |
|
|
2019
Q3 | $10.7M | Sell |
36,678
-7,132
| -16% | -$2.04M | 0.26% | 88 |
|
|
2019
Q2 | $12.9M | Buy |
43,810
+7,132
| +19% | +$1.96M | 0.31% | 81 |
|
|
2019
Q1 | $10M | Sell |
36,678
-8,866
| -19% | -$2.21M | 0.25% | 100 |
|
|
2018
Q4 | $10.2M | Sell |
45,544
-1,356
| -3% | -$318K | 0.28% | 92 |
|
|
2018
Q3 | $11.4M | Sell |
46,900
-7,966
| -15% | -$1.83M | 0.25% | 102 |
|
|
2018
Q2 | $11.4M | Sell |
54,866
-6,469
| -11% | -$1.37M | 0.27% | 88 |
|
|
2018
Q1 | $12.7M | Buy |
61,335
+8,301
| +16% | +$1.74M | 0.26% | 84 |
|
|
2017
Q4 | $10.1M | Sell |
53,034
-383
| -0.7% | -$73.4K | 0.2% | 101 |
|
|
2017
Q3 | $10.1M | Sell |
53,417
-6,000
| -10% | -$1.09M | 0.21% | 94 |
|
|
2017
Q2 | $10.4M | Buy |
59,417
+2,602
| +5% | +$437K | 0.23% | 94 |
|
|
2017
Q1 | $8.73M | Buy |
56,815
+40,000
| +238% | +$6.11M | 0.24% | 104 |
|
|
2016
Q4 | $2.37M | Buy |
+16,815
| New | +$2.48M | 0.07% | 278 |
|
Other funds holding TMO
VCM
Dai-ichi Life Insurance Company's TMO Position: Q1 2026 in Review
Dai-ichi Life Insurance Company increased its Thermo Fisher Scientific (TMO) stake by 1.5% in Q1 2026, buying an estimated $134K and bringing the position to 16,832 shares worth $8.27M. The position accounts for 0.24% of the portfolio, ranked #93.
Dai-ichi Life Insurance Company first reported a position in TMO in Q4 2016 and has held it in 38 quarters since. The position peaked at $32.1M in Q4 2021. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Dai-ichi Life Insurance Company held 16,832 shares of Thermo Fisher Scientific worth $8.27M as of Q1 2026.
- Dai-ichi Life Insurance Company bought 246 Thermo Fisher Scientific shares in Q1 2026, an estimated $134K.
- Thermo Fisher Scientific made up 0.24% of Dai-ichi Life Insurance Company's portfolio in Q1 2026, its #93 holding.
- Dai-ichi Life Insurance Company first reported a position in Thermo Fisher Scientific in Q4 2016 and has held it in 38 quarters since.
- Dai-ichi Life Insurance Company's Thermo Fisher Scientific position peaked at $32.1M in Q4 2021.
- 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Dai-ichi Life Insurance Company's 13F filing for Q1 2026, filed 14 May 2026.